Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Bruce P Ekholm"'
Publikováno v:
Journal of Wound, Ostomy & Continence Nursing. 44:172-180
Purpose The purpose of this study was to evaluate the efficacy of an investigational skin protectant product at managing severe skin breakdown associated with incontinence. Design Open-label, nonrandomized, prospective study. Subjects and setting The
Autor:
Robert A. Asmus, Stéphanie F. Bernatchez, Raha A. Been, Deena M. Conrad-Vlasak, Bruce P. Ekholm, Patrick J. Parks
Publikováno v:
Wound Repair and Regeneration. 24:851-859
A new skin protectant was developed for use on conditions involving partial-thickness skin loss such as severe incontinence-associated dermatitis. This new formulation is based on a cyanoacrylate chemistry designed to polymerize in situ and create a
Publikováno v:
Advances in Wound Care. 4:705-710
Objective: To compare the coefficient of friction (CoF) of skin against fabric when the skin is covered with a liquid barrier film versus a silicone dressing, relative to a bare skin baseline. Approach: A laboratory instrument allowing the measuremen
Publikováno v:
Advances in Wound Care
Objective: To measure the skin temperature after application of a new skin protectant intended for incontinence-associated dermatitis (IAD), compared with a commercial product with an analogous cyanoacrylate-based chemistry. Approach: Twelve healthy
Autor:
Lester I. Harrison, Craig Wagner, Sarala Kurup, Julie S. Larson, Harold B. Kaiser, Bruce P. Ekholm
Publikováno v:
European Journal of Clinical Pharmacology. 58:197-201
The objectives of this study were to test the dose and strength proportionalities of beclomethasone dipropionate (BDP) delivered from two strengths of a pressurized extrafine solution formulation.Thirty adults with mild, stable asthma, aged between 1
Autor:
Ann C. Cline, Bruce P. Ekholm, Inmaculada Soria, Jane H. Machacek, Paula Myhre, Lester I. Harrison, Anthony Pierce, Angela Helget, Zengri Wang
Publikováno v:
Clinical Drug Investigation. 22:523-531
Objective: To assess the bioequivalence of beclomethasone dipropionate (BDP) delivered from a press-and-breathe (PB) inhaler and a breath-actuated inhaler (Autohaler™, AH). Design: Two randomised, open-label, single-dose, four-period crossover stud
Publikováno v:
Journal of Pharmacy and Pharmacology. 51:1235-1240
We have compared the serum pharmacokinetics of the metabolites of beclomethasone dipropionate after inhalation from chlorofluorocarbon (CFC) and hydrofluoroalkane HFA-134a (HFA) formulations in asthmatic patients. Twenty-three patients completed this
Publikováno v:
Chest. 115:945-951
Background Chlorofluorocarbons (CFCs) used as propellants in metered-dose inhalers deplete stratospheric ozone, which results in serious public health concerns. Albuterol has been reformulated in the non-ozone-depleting propellant, hydrofluoroalkane-
Publikováno v:
Journal of Asthma. 36:671-676
Short-acting inhaled beta2-agonists used just prior to exercise are an effective method for preventing exercise-induced bronchoconstriction (EIB) in children. This was a randomized, single-blind, placebo-controlled, four-period crossover study that c
Publikováno v:
Annals of Allergy, Asthma & Immunology. 81:593-599
As a result of the pending ban on chlorofluorocarbon production, the non-chlorofluorocarbon propellant 1,1,1,2-tetrafluoroethane (HFA-134a) is being evaluated as a replacement for CFCs in metered-dose inhalers.This cumulative dose response study comp